12/26/2012

An experimental drug called AC253, which was designed to treat diabetes, could block the effects of amyloid proteins that cause brain cells to die in patients with Alzheimer's disease, Canadian researchers say. The study, reported in The Journal of Neuroscience, showed that when the drug was injected into brain cells of an animal model with Alzheimer's disease, memory function was restored to near-normal levels.

Related Summaries